The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy
Abstract
Aims: Sudden cardiac death (SCD) is a common mode of death in hypertrophic cardiomyopathy (HCM), but identification of patients who are at a high risk of SCD is challenging as current risk stratification guidelines have never been formally validated. The objective of this study was to assess the power of the 2003 American College of Cardiology (ACC)/European Society of Cardiology (ESC) and 2011 ACC Foundation (ACCF)/American Heart Association (AHA) SCD risk stratification algorithms to distinguish high risk patients who might be eligible for an implantable cardioverter defibrillator (ICD) from low risk individuals. Methods and results: We studied 1606 consecutively evaluated HCM patients in an observational, retrospective cohort study. Five risk factors (RF) for SCD were assessed: non-sustained ventricular tachycardia, severe left ventricular hypertrophy, family history of SCD, unexplained syncope and abnormal blood pressure response to exercise. During a follow-up period of 11 712 patient years (median 6.6 years), SCD/appropriate ICD shock occurred in 20 (3%) of 660 patients without RF (annual rate 0.45%), 31 (4.8%) of 636 patients with 1 RF (annual rate 0.65%), 27 (10.8%) of 249 patients with 2 RF (annual rate 1.3%), 7 (13.7%) of 51 patients with 3 RF (annual rate 1.9%) and 4 (40%) of 10 patients with ≥4 RF (annual rate 5.0%). The risk of SCD increased with multiple RF (2 RF: HR 2.87, p≤0.001; 3 RF: HR 4.32, p=0.001; ≥4 RF: HR 11.37, p<0.0001), but not with a single RF (HR 1.43 p=0.21). The area under time-dependent receiver operating characteristic curves (representing the probability of correctly identifying a patient at risk of SCD on the basis of RF profile) was 0.63 at 1 year and 0.64 at 5 years for the 2003 ACC/ESC algorithm and 0.61 at 1 year and 0.63 at 5 years for the 2011 ACCF/AHA algorithm. Conclusions: The risk of SCD increases with the aggregation of RF. The 2003 ACC/ESC and 2011 ACCF/AHA guidelines distinguish high from low risk individuals with limited power.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistics Notes: Diagnostic tests 2: predictive values
Altman, D. G., & Bland, J. M. (1994) · BMJ · doi:10.1136/bmj.309.6947.102 · Cited by 1,711
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459
Syncope and risk of sudden death in hypertrophic cardiomyopathy
Spirito, P., Autore, C., Rapezzi, C., Bernabò, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N. A. M., Barillà, C. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.798314 · Cited by 365
Christiaans, I., van Engelen, K., van Langen, I. M., Birnie, E., Bonsel, G. J., Elliott, P. M., & Wilde, A. A. M. (2010) · EP Europace · doi:10.1093/europace/eup431 · Cited by 176
Research works printed but not linked: 39
- 10.1161/01.CIR.102.8.858 · DOI · Paper page
- 10.1136/hrt.2005.068577 · DOI · Paper page
- 10.1016/S0735-1097(00)01003-2 · DOI · Paper page
- 10.1016/S0195-668X(03)00479-2 · DOI · Paper page
- 10.1161/CIR.0b013e318223e230 · DOI · Paper page
- 10.1136/hrt.2010.217182 · DOI · Paper page
- 10.1093/eurheartj/ehm342 · DOI · Paper page
- 10.1136/hrt.77.2.130 · DOI · Paper page
- 10.1161/01.CIR.96.9.2987 · DOI · Paper page
- 10.1093/eurheartj/ehl041 · DOI · Paper page
- 10.1093/eurheartj/ehp327 · DOI · Paper page
- 10.1111/j.0006-341X.2000.00337.x · DOI · Paper page
- 10.1148/radiology.143.1.7063747 · DOI · Paper page
- 10.1056/NEJM198008073030607 · DOI · Paper page
- 10.1046/j.1460-9592.2003.00285.x · DOI
- 10.1136/hrt.2008.150656 · DOI · Paper page
- 10.1001/jama.298.4.405 · DOI · Paper page
- 10.1016/S0735-1097(98)00037-0 · DOI
- 10.1136/hrt.2006.090290 · DOI
- 10.1136/hrt.2006.094730 · DOI
- 10.1157/13089740 · DOI
- Syska, 2010, Implantable cardioverter-defibrillator in patients With hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up, J Cardiovasc Electrophysiol, 21, 883, 10.1111/j.1540-8167.2009.01716.x · DOI
- Harrell FE . Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. 1 edn. Springer-Verlag, New York, USA, 2001. · DOI
- 10.1016/j.amjcard.2005.11.048 · DOI · Paper page
- 10.1016/S0140-6736(00)04005-8 · DOI · Paper page
- 10.1093/eurheartj/ehq308 · DOI
- 10.1161/CIRCULATIONAHA.111.023846 · DOI · Paper page
- 10.1056/NEJMoa0909545 · DOI · Paper page
- 10.1378/chest.09-1584 · DOI · Paper page
- 10.1016/S0735-1097(99)00094-7 · DOI · Paper page
- 10.1093/eurheartj/ehi688 · DOI
- 10.1136/hrt.2003.030353 · DOI
- 10.1016/S0002-9149(98)00455-X · DOI · Paper page
- 10.1016/S0735-1097(98)00555-5 · DOI
- 10.1056/NEJM200006153422403 · DOI · Paper page
- 10.1016/S0735-1097(02)03004-8 · DOI · Paper page
- 10.1016/S0735-1097(03)00827-1 · DOI · Paper page
- 10.1016/j.jcmg.2011.11.021 · DOI · Paper page
- 10.1016/j.jacc.2005.02.090 · DOI · Paper page
Cited by
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Self-citationPriori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Self-citation(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251
Self-citationOmmen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 994
Self-citation
Metadata
- Authors
- O'Mahony, C., Tome-Esteban, M., Lambiase, P. D., Pantazis, A., Dickie, S., McKenna, W. J., & Elliott, P. M.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2013-01-22
- Volume
- 99
- Issue
- 8
- Pages
- 534-541
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2156505087
- Cited by
- 159
- References
- 4
- FWCI
- 14.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. https://app.cochat.ai/papers/10.1136/heartjnl-2012-303271
- The paper
- O'Mahony, C., Tome-Esteban, M., Lambiase, P. D., Pantazis, A., Dickie, S., McKenna, W. J., & Elliott, P. M. (2013). A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. Heart. https://doi.org/10.1136/heartjnl-2012-303271
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.